A multifaceted cancer immunotherapy based on an immune checkpoint-modulating chimeric oncolytic virus vector in combination with a dendritic cell vaccine

Project description

Multifaceted oncolytic virus-based approach for cancer immunotherapy

Fields of science

• medical and health sciences › health sciences › public and environmental health › epidemics prevention › immunisation
• natural sciences › biological sciences › microbiology › virology
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drug › vaccines
• medical and health sciences › basic medicine › immunology › immunotherapy
• medical and health sciences › clinical medicine › cancer

Programme(s)

• H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)

Topic(s)

• ERC-2019-STG - ERC Starting Grant

Call for proposal

ERC-2019-STG
See other projects for this call

Funding Scheme

ERC-STG - Starting Grant

Host institution

KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN

Address

Ismaninger Strasse 22
81675 Muenchen
Germany

Activity type

Higher or Secondary Education Establishments

EU contribution

€ 1 499 988

Beneficiaries (1)

KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN

Germany

EU contribution

€ 1 499 988

Address

Ismaninger Strasse 22
81675 Muenchen

Activity type

Higher or Secondary Education Establishments